Pathophysiological Insights Into the Role of Osteoclasts in Osteoarthritis: Mechanisms, Therapeutic Targets, and Future Directions
- PMID: 40851840
- PMCID: PMC12369642
- DOI: 10.2147/JIR.S525245
Pathophysiological Insights Into the Role of Osteoclasts in Osteoarthritis: Mechanisms, Therapeutic Targets, and Future Directions
Abstract
Osteoarthritis (OA) is the most prevalent musculoskeletal issue. In the absence of effective pharmacological interventions, advanced stages of this disease frequently necessitate joint replacement surgery, thereby imposing a substantial socioeconomic burden. An increasing number of studies suggest that subchondral bone osteoclasts are crucial for the onset of arthritis, even before the formation of cartilage lesions. Osteoclasts are the only type of cells responsible for bone resorption and are integral to the etiology of OA. Subchondral osteoclasts accelerate OA progression by mediating cartilage damage, promoting angiogenesis, and mediating neuropathic pain. With advancements in knowledge of bone biology and focused medicines, OA therapeutics for osteoclasts are gradually being revealed. This article presents an examination of the function and processes that regulate subchondral osteoclasts in OA, detailing recent breakthroughs in targeted therapy for osteoarthritis involving subchondral osteoclasts. The aim of this study is to address the current knowledge gap in OA treatment and promote the advancement of innovative therapeutic approaches. Notably, combining single-cell RNA sequencing (scRNA-seq) with traditional therapeutic approaches to investigate the gene expression patterns of osteoclasts in OA from both temporal and spatial dimensions may lead to the discovery of novel OA treatment targets.
Keywords: angiogenesis; osteoarthritis; osteoclast; pain; single-cell sequencing.
© 2025 Chen et al.
Conflict of interest statement
The authors declare that they have no competing interests. Graphical abstract Created in BioRender. Chen, S. (2025) https://BioRender.com/b69db0n.
Figures




Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
How Does the Subchondral Bone Density Distribution of the Distal Humerus Change Between Early and Advanced Stages of Osteoarthritis?Clin Orthop Relat Res. 2024 Jul 1;482(7):1210-1215. doi: 10.1097/CORR.0000000000002921. Epub 2023 Nov 15. Clin Orthop Relat Res. 2024. PMID: 37966302 Free PMC article.
-
Cellular and molecular mechanisms underlying subchondral bone remodeling and associated pain in osteoarthritis.Connect Tissue Res. 2025 Aug 13:1-7. doi: 10.1080/03008207.2025.2540950. Online ahead of print. Connect Tissue Res. 2025. PMID: 40801485
-
Transformative approaches for effective clinical trials to reduce the disease burden of osteoarthritis.Semin Arthritis Rheum. 2025 Apr;71:152652. doi: 10.1016/j.semarthrit.2025.152652. Epub 2025 Feb 3. Semin Arthritis Rheum. 2025. PMID: 39970622 Review.
-
Osteoarthritis in cats: what we know, and mostly, what we don't know. . . yet.J Feline Med Surg. 2025 Jul;27(7):1098612X251347999. doi: 10.1177/1098612X251347999. Epub 2025 Jul 20. J Feline Med Surg. 2025. PMID: 40685570 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous